Bitcoin ETFs finished the week with $223 million in net inflows, while Ether ETFs held positive at $48 million despite heavy redemptions across multiple funds. Blackrock’s vehicles once again carried the momentum for both markets. Bitcoin and Ether ETFs End the Week in Green With $271 Million in Combined Inflows The week ended with a […]Bitcoin ETFs finished the week with $223 million in net inflows, while Ether ETFs held positive at $48 million despite heavy redemptions across multiple funds. Blackrock’s vehicles once again carried the momentum for both markets. Bitcoin and Ether ETFs End the Week in Green With $271 Million in Combined Inflows The week ended with a […]
Crypto ETFs Close Week Strong Despite Broad Outflows in Ether Funds
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다
Bitcoin ETFs finished the week with $223 million in net inflows, while Ether ETFs held positive at $48 million despite heavy redemptions across multiple funds. Blackrock’s vehicles once again carried the momentum for both markets. Bitcoin and Ether ETFs End the Week in Green With $271 Million in Combined Inflows The week ended with a […]
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.
추천 콘텐츠
Immutep (IMM) Stock Doubles on FDA Orphan Drug Win for Rare Cancer Drug
TLDR Immutep stock jumped over 101% on Wednesday after receiving FDA Orphan Drug Designation for eftilagimod alfa (efti). The designation covers soft tissue sarcoma
공유하기
Coincentral2026/04/15 20:09
XRP flashes golden cross signal: Is $5 next?
The post XRP flashes golden cross signal: Is $5 next? appeared on BitcoinEthereumNews.com. As XRP continues to consolidate, its technical structure is flashing
공유하기
BitcoinEthereumNews2026/04/15 20:34
Immutep (IMM) Shares Soar 101% Following FDA Orphan Drug Status for Cancer Therapy
Immutep (IMM) stock soared 101% after FDA granted Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma. Market exclusivity & tax benefits await.
공유하기
Blockonomi2026/04/15 20:19
